Notably, a loss of function mutation in the NR1H3 gene encoding LXRα in patients presenting with a rare genetic form of severe progressive MS, indicates that aberrant LXR signaling could be involved in MS progression (120). The gene discussed is NR1H3; the disease is myeloid sarcoma.